Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934603 · ClinicalTrials.gov registry record
Microplastic Exposure From Clear Aligner Wear (MPE)
A clinical trial of Microplastic Exposure, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06934603: Recruiting study of Microplastic Exposure, sponsored by University of North Carolina, Chapel Hill.
NCT06934603 is a study of Microplastic Exposure that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06934603, a study of Microplastic Exposure, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
An observational longitudinal study measuring microplastic exposure and physiologic uptake in orthodontic patients receiving clear aligner treatment.
Primary Outcome
Differences in microplastic abundance in saliva collected pre-treatment with clear aligners, 6-12 weeks post-treatment, and 16-24 weeks post-treatment.
Conditions Studied
Interventions
- OTHER Clear Aligner Treatment
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-08-08 |
| Est. Completion | 2035-07-01 |
What NCT06934603 shows while recruiting
NCT06934603 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Microplastic Exposure appearing as the primary indexed condition, and to 1 intervention - of which Clear Aligner Treatment is the first listed.
NCT06934603 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06934603 about?
NCT06934603 is a clinical study titled "Microplastic Exposure From Clear Aligner Wear (MPE)". An observational longitudinal study measuring microplastic exposure and physiologic uptake in orthodontic patients receiving clear aligner treatment.
What is the current status of trial NCT06934603?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-08-08. Estimated completion is 2035-07-01.
What conditions does trial NCT06934603 study?
This clinical trial studies the following conditions: Microplastic Exposure.
What interventions are being tested in trial NCT06934603?
The interventions under investigation include: Clear Aligner Treatment (OTHER).
Who is sponsoring clinical trial NCT06934603?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06934603 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI